Last checked at 12 Aug 2008 07:00
| For immediate release | 12 August 2008 |
Advanced Medical Solutions Group plc
("AMS" or "the Company")
Notice of Interim Results
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global woundcare technology company, will announce its interim results for the six months ended 30 June 2008 on Tuesday 9 September 2008.
An analyst briefing will be held at 9.30am at Buchanan Communications, 45 Moorfields, London EC2, on the day of the announcement.
For further information, please contact:
| Advanced Medical Solutions Group plc | +44 (0) 01606 545508 |
| Don Evans, Chief Executive Officer | |
| Mary Tavener, Group Finance Director | |
| www.admedsol.com | |
| Buchanan Communications | +44 (0) 020 7466 5000 |
| Mark Court / Mary-Jane Johnson / Stasa Filiplic | |
| Landsbanki Securities (UK) Ltd Shaun Dobson, Claes Spang | +44 (0) 20 7426 9000 |
Notes to Editors
Advanced Medical Solutions is a leading company in the development, manufacture and sale of products into the $15 billion global woundcare market.
Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.
In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery ready for distribution into customer markets.
AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection.
AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.